Data Availability
The data that support the findings of this study are not openly available due to reasons of sensitivity and protection of participant privacy. An anonymized version may be made available from the corresponding author upon reasonable request. Data are located in controlled access data storage at the Providence VA Medical Center.
References
Oakes AH, Boyce K, Patton C, Jain S. Rates of routine Cancer screening and diagnosis before vs after the COVID-19 pandemic. JAMA Oncol. 2023;9(1):145–6. https://doi.org/10.1001/jamaoncol.2022.5481.
Bernacki K, Keister A, Sapiro N, Joo JS, Mattle L. Impact of COVID-19 on patient and healthcare professional attitudes, beliefs, and behaviors toward the healthcare system and on the dynamics of the healthcare pathway. BMC Health Serv Res. 2021;21(1):1309. https://doi.org/10.1186/s12913-021-07237-y. Published 2021 Dec 6.
Rex DK, Boland CR, Dominitz JA, et al. Colorectal Cancer screening: recommendations for Physicians and patients from the U.S. Multi-society Task Force on Colorectal Cancer. Gastroenterology. 2017;153(1):307–23.
Liu PH, Singal AG, Murphy CC. Stool-based tests mitigate impacts of COVID-19 on Colorectal Cancer Screening. Clin Gastroenterol Hepatol. 2023;21(6):1667–e16692. https://doi.org/10.1016/j.cgh.2022.12.014.
Coronado GD, Nyongesa DB, Petrik AF, et al. Randomized Controlled Trial of Advance notification phone calls vs text messages prior to Mailed Fecal Test Outreach. Clin Gastroenterol Hepatol. 2021;19(11):2353–e23602. https://doi.org/10.1016/j.cgh.2020.07.053.
Lee B, Keyes E, Rachocki C, et al. Increased Colorectal Cancer Screening sustained with mailed fecal immunochemical test Outreach. Clin Gastroenterol Hepatol. 2022;20(6):1326–e13334. https://doi.org/10.1016/j.cgh.2021.07.022.
Goshgarian G, Sorourdi C, May FP, et al. Effect of patient portal messaging before mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: a Randomized Clinical Trial. JAMA Netw Open. 2022;5(2):e2146863. https://doi.org/10.1001/jamanetworkopen.2021.46863. Published 2022 Feb 1.
Gordon NP, Green BB. Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study. BMC Public Health. 2015;15:546. Published 2015 Jun 11. https://doi.org/10.1186/s12889-015-1908-x.
Kanth P, Inadomi JM. Screening and prevention of colorectal cancer. BMJ. 2021;374:n1855. Published 2021 Sep 15. https://doi.org/10.1136/bmj.n1855.
Funding
No financial disclosures were reported by the authors of this paper.
Author information
Authors and Affiliations
Contributions
Conceptualization: K.M.; Data curation: K.M.; Formal Analysis: K.M.; Funding acquisition: N/A; Investigation: K.M.; Methodology: K.M.; Project administration: K.M.; Resources: N/A; Software: N/A; Supervision: K.P., Y.E.; Validation: K.M.; Visualization: K.M.; Writing – original draft: K.M.; Writing – review & editing: K.M., K.P., Y.E. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Ethical approval
This is an observational study. The Providence Veterans Affairs Medical Center has confirmed that no ethical approval is required.
Conflict of interest
None of the authors have funding sources or institutional and corporate affiliations that supported this work.
Grant support
Not applicable.
Writing assistance
Not applicable.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Malani, K., Elfanagely, Y. & Promrat, K. Understanding Patient Perspectives to Improve Colorectal Cancer Screening Following the COVID-19 Pandemic: Assessment of a Mailed Fecal Immunochemical Testing Program. J Gastrointest Canc (2024). https://doi.org/10.1007/s12029-024-01041-7
Accepted:
Published:
DOI: https://doi.org/10.1007/s12029-024-01041-7